• Aucun résultat trouvé

18 résultats avec le mot-clé: 'tyrosine kinase required transforming activity fibroblasts breast cancer'

The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.

ERK5 activity of cells were treated with 5 µM SU6656, 10 µM Imatinib or vehicle (DMSO) Autophosphorylated ERK5 ( 32 P-ERK5), phosphorylation of MEF2C ( 32 P-MEF2C), levels of

Protected

N/A

41
0
0
2021
Samsung August 2007 Link-Layer Event Notifications for Detecting Network Attachments Status of This Memo This memo provides information for the Internet community

Additional information can be conveyed along with the event, such as the identifier of the network attachment point (e.g., IEEE 802.11 Basic Service Set Identification (BSSID)

Protected

N/A

18
0
0
2022
The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities.

The Tom1L1- clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities.... The Tom1L1-Clathrin

Protected

N/A

42
0
0
2021
Primary T cell immunodeficiencies associated with disturbed proximal T cell receptor signalling caused by human autosomal recessive LCK, ZAP-70 and ITK-mutations

Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.. Enhancement of lymphocyte responsiveness

Protected

N/A

205
0
0
2021
Les Effets de commerce

La lettre de change est un document par lequel, une personne appelée Tireur donne l’ordre à une autre personne appelée Tiré de payer une somme déterminée, à une date

Protected

N/A

14
0
0
2022
Targeting the extra-cellular matrix—tumor cell crosstalk for anti-cancer therapy: emerging alternatives to integrin inhibitors

ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits

Protected

N/A

17
0
0
2021
TRANSFORMING BREAST CANCER TOGETHER

The ‘Transforming Breast Cancer Together’ initiative was established when influential policy makers and organizations strongly committed to cancer care began to collaborate following

Protected

N/A

13
0
0
2022
Quiz: Vive la France!

 Une feuille (avec les numéros des questions) préparée par le prof et un stylo par groupe (pour pouvoir noter les réponses)..  Des photos des bâtiments / des édifices

Protected

N/A

1
0
0
2022
Appendix 1.

Number of individuals, species richness, diversity (ind./spp), consumed plant individuals and their proportion (Ind. Prop.), total basal area (BA) of consumed species, and

Protected

N/A

4
0
0
2022
loup noir

[r]

Protected

N/A

1
0
0
2022
EGFR inhibition by curcumin in cancer cells: a dual mode of action.

Inhibitory effect of curcumin on EGFR tyrosine kinase domain activity. The tyrosine kinase inhibitory effect of curcumin on a recombinant, 695-end, active human EGFR

Protected

N/A

34
0
0
2021
Rôle potentiel du phosphatidylinositol 5-phosphate dans l'oncogenèse associée à NPM-ALK : implication de PIKfyve

(2001) Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.. (2004) Ent5p is required

Protected

N/A

237
0
0
2021
Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma.

Somatic mutations of EGFR at tyrosine kinase domain have been associated with clinical response to tyrosine kinase inhibitors (TKIs) in lung cancer patients.. In this study,

Protected

N/A

6
0
0
2021
PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells

We demonstrate here that in cancer cells harboring met gene amplification, inhibition of Met activity with tyrosine kinase inhibitors or specific siRNA drastically decreased

Protected

N/A

17
0
0
2021
Comité de Rédaction

Le texte comporte trois parties consacrées à des aspects variés et complémentaires de la théorie : aspects analytiques (méthodes L²), algébriques (utilisation de la

Protected

N/A

4
0
0
2022
The ENCCA‑WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report

ABCB1: ATP‑binding cassette transporter B1; ATM‑CHEK1: aven‑ATM serine/ threonine kinase‑checkpoint kinase 1; AXL: AXL receptor tyrosine kinase; BCOR: BCL6 co‑repressor;

Protected

N/A

10
0
0
2021
Cancer-associated fibroblasts: Accomplices in the tumor immune evasion

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model.. FAP positive fibroblasts

Protected

N/A

24
0
0
2021
Molecular environment of iodine in naturally iodinated humic substances: Insight from X-ray absorption spectroscopy

The molecular environment of iodine in reference inorganic and organic compounds, and in dry humic and fulvic acids (HAs and FAs) extracted from subsurface and deep aquifers was

Protected

N/A

17
0
0
2021

Télécharger plus de documents et télécharger des études de documentation immédiatement !